<DOC>
	<DOCNO>NCT01709682</DOCNO>
	<brief_summary>The hypothesis study early re-ablation ( test ) superior AAD therapy ( control ) patient previous fail PVI ablation paroxysmal AF .</brief_summary>
	<brief_title>A Comparison Drug Therapy Versus Re-Ablation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<mesh_term>Sotalol</mesh_term>
	<mesh_term>Flecainide</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<mesh_term>Propafenone</mesh_term>
	<criteria>history symptomatic PAF congestive heart failure LV ejection fraction &lt; 35 % leave atrial diameter &gt; 60 mm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>arrhythmia</keyword>
	<keyword>anti-arrhythmic agent</keyword>
</DOC>